Dermal Fillers
OLIDIA references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 10970
Olidia 240
In stock
Volume
1 x 243,4 mg
Laboratory
PRP Life Science Co., Ltd.
Origin
South Korea
Indication
Moderate to severe nasolabial folds
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler from the OLIDIA range (manufacturer PRP SCIENCE Co., Ltd., South Korea). It contains PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial. Olidia 240 is intended for professional use, to temporarily improve moderate to severe nasolabial folds by injection into the deep dermis or subcutaneous (subdermal) layer.
Key Benefits of Olidia 240
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
Indications and Professional Use
Main indications
- Moderate to severe nasolabial folds
Professional use
For professional use only, by trained physicians. Olidia 240 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
Treatment areas
- Moderate to severe nasolabial folds.
Patient profile
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
How Olidia 240 Works
Olidia 240 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
Why Order From Allpara
Allpara offers genuine, verified OLIDIA products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
What is Olidia 240 used for?
Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 240 formula?
Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.
Where is Olidia 240 injected?
Olidia 240 is injected into the deep dermis or subdermal layer.
More from PRP Life Science
Clinic alternatives
Collagen Stimulators
/ Recently viewed
Pick up where you left off
Olidia 240
In stock
CE Marked
Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler from the OLIDIA range (manufacturer PRP SCIENCE Co., Ltd., South Korea). It contains PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial. Olidia 240 is intended for professional use, to temporarily improve moderate to severe nasolabial folds by injection into the deep dermis or subcutaneous (subdermal) layer.
Key Benefits of Olidia 240
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
Indications and Professional Use
Main indications
- Moderate to severe nasolabial folds
Professional use
For professional use only, by trained physicians. Olidia 240 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
Treatment areas
- Moderate to severe nasolabial folds.
Patient profile
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
How Olidia 240 Works
Olidia 240 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
Why Order From Allpara
Allpara offers genuine, verified OLIDIA products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
What is Olidia 240 used for?
Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 240 formula?
Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.
Where is Olidia 240 injected?
Olidia 240 is injected into the deep dermis or subdermal layer.
More from PRP Life Science
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.